Joint Filing AgreementJoint Filing Agreement • February 12th, 2019 • Biotechnology Value Fund L P • Investment advice
Contract Type FiledFebruary 12th, 2019 Company IndustryThe undersigned hereby agree that the Statement on Schedule 13G dated February 11, 2019 with respect to the Common Shares, par value CHF 0.02 per share of AC Immune SA, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.